GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Megasoft Ltd (NSE:MEGASOFT) » Definitions » Cyclically Adjusted PS Ratio

Megasoft (NSE:MEGASOFT) Cyclically Adjusted PS Ratio : (As of Jun. 16, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Megasoft Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Megasoft Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Megasoft's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Megasoft Cyclically Adjusted PS Ratio Chart

Megasoft Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.40 2.82 - -

Megasoft Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Megasoft's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Megasoft's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Megasoft's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Megasoft's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Megasoft's Cyclically Adjusted PS Ratio falls into.



Megasoft Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Megasoft's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Megasoft's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/153.0345*153.0345
=0.000

Current CPI (Mar. 2024) = 153.0345.

Megasoft Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 3.833 94.103 6.233
201409 3.860 96.780 6.104
201412 2.904 96.780 4.592
201503 0.000 97.163 0.000
201506 2.694 99.841 4.129
201509 2.747 101.753 4.131
201512 2.679 102.901 3.984
201603 4.376 102.518 6.532
201606 2.610 105.961 3.769
201609 2.768 105.961 3.998
201612 3.854 105.196 5.607
201703 3.974 105.196 5.781
201706 2.974 107.109 4.249
201709 3.217 109.021 4.516
201712 3.451 109.404 4.827
201803 3.030 109.786 4.224
201806 2.712 111.317 3.728
201809 2.548 115.142 3.387
201812 2.638 115.142 3.506
201903 3.081 118.202 3.989
201906 2.395 120.880 3.032
201909 2.724 123.175 3.384
201912 3.137 126.235 3.803
202003 3.007 124.705 3.690
202006 2.522 127.000 3.039
202009 3.574 130.118 4.203
202012 3.711 130.889 4.339
202103 2.936 131.771 3.410
202106 2.850 134.084 3.253
202109 1.719 135.847 1.936
202112 1.813 138.161 2.008
202203 1.900 138.822 2.095
202206 0.269 142.347 0.289
202209 0.000 144.661 0.000
202212 0.000 145.763 0.000
202303 0.000 146.865 0.000
202306 0.000 150.280 0.000
202309 0.000 151.492 0.000
202312 0.000 152.924 0.000
202403 0.000 153.035 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Megasoft  (NSE:MEGASOFT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Megasoft Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Megasoft's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Megasoft (NSE:MEGASOFT) Business Description

Traded in Other Exchanges
Address
Image Gardens Road, 8th Floor, Unit No. 801B, Plot No. 1, 28 & 29, 98/4/1 to 13, Jain Sadguru Image’s Capital Park, Madhapur, Hyderabad, TG, IND, 500081
Megasoft Ltd is focused on Pharma, Aerospace and Defense Electronics areas and is in the process of acquiring a few companies and intends to provide centralized corporate, technology, finance, and leadership/management support services to such subsidiaries/associate companies. The company has invested in Extrovis AG, a company engaged in Pharmaceutical R&D and in the business of development, production, distribution and sale of chemicals and pharmaceuticals of all kinds has a wide range of activities aimed at bringing safe, effective, and high-quality drugs to the market.

Megasoft (NSE:MEGASOFT) Headlines

No Headlines